J. Que

发表

Immunogenicity of trivalent subunit versus virosome-formulated influenza vaccines in geriatric patients.

S. Cryz, R. Glück, P. Vernet, 1997, Vaccine.

Immunogenicity of new virosome influenza vaccine in elderly people

S. Cryz, R. Glück, R. Mischler, 1994, The Lancet.

Prospects for Prevention of Vertical Transmission of Human Immunodeficiency Virus by Immunization

S. Cryz, A. Rubinstein, E. Fuerer, 1993, Annals of the New York Academy of Sciences.

Antibody responses induced by long-term vaccination with an octovalent conjugate Pseudomonas aeruginosa vaccine in children with cystic fibrosis.

A. Zuercher, U. Schaad, A. Lang, 2006, FEMS immunology and medical microbiology.

Mucosal and Systemic Immune Responses in Humans after Primary and Booster Immunizations with Orally Administered Invasive and Noninvasive Live Attenuated Bacteria

D. Favre, S. Cryz, J. Viret, 1999, Infection and Immunity.

Human immunodeficiency virus-1 principal neutralizing domain peptide-toxin A conjugate vaccine.

S. Cryz, A. Rubinstein, E. Fuerer, 1995, Vaccine.

Immunization of cystic fibrosis patients with a Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine.

S. Cryz, U. Schaad, A. Lang, 1997, Behring Institute Mitteilungen.

Affinity constants of naturally acquired and vaccine-induced anti-Pseudomonas aeruginosa antibodies in healthy adults and cystic fibrosis patients.

S. Cryz, U. Schaad, A. Lang, 1992, The Journal of infectious diseases.

Safety and immunogenicity of Escherichia coli O18 O-specific polysaccharide (O-PS)-toxin A and O-PS-cholera toxin conjugate vaccines in humans.

A. Cross, S. Cryz, J. Sadoff, 1991, The Journal of infectious diseases.

Local and systemic immune responses to combined vibrio cholerae CVD103-HgR and salmonella typhi ty21a live oral vaccines after primary immunization and reimmunization.

S. Cryz, C. Herzog, A. Lang, 2000, Vaccine.

Purification of Pseudomonas aeruginosa exoenzyme S

D. Woods, J. Que, 1987, Infection and immunity.

Safety and immunogenicity of combined diphtheria-tetanus-pertussis (whole cell and acellular)-Haemophilus influenzae-b conjugate vaccines administered to Indonesian children.

C. Simanjuntak, N. Punjabi, E. Richie, 1999, Vaccine.

A virosome vaccine antigen delivery system does not stimulate an antiphospholipid antibody response in humans.

S. Cryz, R. Glück, J. Que, 1996, Vaccine.

Effect of carrier selection on immunogenicity of protein conjugate vaccines against Plasmodium falciparum circumsporozoites

S. Cryz, L. Loomis, E. Fuerer, 1988, Infection and immunity.

Unusual persistence in healthy volunteers and ill patients of hyperimmune immunoglobulin directed against multiple Pseudomonas O-chain and Klebsiella serotypes after intravenous infusion.

J. McClain, A. Cross, S. Cryz, 2001, Vaccine.

Immunological cross-reactivity between Enterobacter aerogenes and Klebsiella capsular polysaccharides.

T. Pitt, S. Cryz, B. Ayling-Smith, 1990, Microbial pathogenesis.

Vaccination of Cystic Fibrosis Patients Against Pseudomonas aeruginosa Reduces the Proportion of Patients Infected and Delays Time to Infection

U. Schaad, A. Lang, E. Fuerer, 2004, The Pediatric infectious disease journal.

Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis.

S. Cryz, U. Schaad, A. Lang, 1995, The Journal of pediatrics.

Safety and immunogenicity of Pseudomonas aeruginosa conjugate A vaccine in cystic fibrosis

S. Cryz, U. Schaad, A. Lang, 1991, The Lancet.

Safety, immunogenicity, and efficacy of a Plasmodium falciparum vaccine comprising a circumsporozoite protein repeat region peptide conjugated to Pseudomonas aeruginosa toxin A

J. Beier, S. Cryz, I. Schneider, 1992, Infection and immunity.

Safety and immunogenicity of two Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccines (PRP-T) given with diphtheria-tetanus-pertussis vaccine to young Papua New Guinean children.

M. Alpers, D. Lehmann, C. Herzog, 2001, Papua and New Guinea medical journal.

Alteration of pulmonary structure by Pseudomonas aeruginosa exoenzyme S.

D. Woods, J. Que, M. Shahrabadi, 1988, Journal of medical microbiology.

Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine.

S. Cryz, T. Chotpitayasunondh, U. Thisyakorn, 2000, Bulletin of the World Health Organization.

Human IgG and IgA subclass response following immunization with a polyvalent Klebsiella capsular polysaccharide vaccine

A. Cross, S. Cryz, J. Que, 1988, European journal of immunology.

Effect of streptomycin administration on colonization resistance to Salmonella typhimurium in mice

J. Que, D. Hentges, David J. I-ENTGES, 1985, Infection and immunity.

Production and characterization of a human hyperimmune intravenous immunoglobulin against Pseudomonas aeruginosa and Klebsiella species.

A. Cross, S. Cryz, J. Sadoff, 1991, The Journal of infectious diseases.

Efficacy of atovaquone/proguanil for malaria prophylaxis in children and its effect on the immunogenicity of live oral typhoid and cholera vaccines.

B. Lell, P. Kremsner, J. Faucher, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Protective role of intestinal flora against infection with Pseudomonas aeruginosa in mice: influence of antibiotics on colonization resistance

J. Que, D. Hentges, A. Stein, 1985, Infection and immunity.

Immunity against Pseudomonas aeruginosa adoptively transferred to bone marrow transplant recipients

H. Prentice, S. Cryz, M. Brenner, 1990 .

Immunotherapy of sepsis: flawed concept or faulty implementation?

P. Peduzzi, S. Opal, A. Cross, 1999, Vaccine.

Immunization of noncolonized cystic fibrosis patients against Pseudomonas aeruginosa.

S. Cryz, U. Schaad, A. Lang, 1994, The Journal of infectious diseases.

Clinical evaluation of an octavalent Pseudomonas aeruginosa conjugate vaccine in plasma donors and in bone marrow transplant and cystic fibrosis patients.

S. Cryz, J. Sadoff, U. Schaad, 1991, Antibiotics and chemotherapy.

Factors responsible for increased susceptibility of mice to intestinal colonization after treatment with streptomycin

J. Que, D. Hentges, S. W. Casey, 1986, Infection and immunity.

Synthesis and characterization of a Pseudomonas aeruginosa alginate-toxin A conjugate vaccine

S. Cryz, E. Fuerer, J. Que, 1991, Infection and immunity.

Plasmodium falciparum circumsporozoite vaccine immunogenicity and efficacy trial with natural challenge quantitation in an area of endemic human malaria of Kenya.

G. Strickland, J. Wittes, R. Wirtz, 1996, Vaccine.

Phase 1 trial of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered simultaneously.

J. McClain, A. Cross, D. N. Taylor, 1994, Vaccine.

Safety and immunogenicity of a live oral bivalent typhoid fever (Salmonella typhi Ty21a)-cholera (Vibrio cholerae CVD 103-HgR) vaccine in healthy adults

M. Levine, S. Cryz, G. Wiedermann, 1995, Infection and immunity.

Randomized, double-blind placebo-controlled trial to evaluate the safety and immunogenicity of combined Salmonella typhi Ty21a and Vibrio cholerae CVD 103-HgR live oral vaccines

S. Cryz, C. Herzog, G. Wiedermann, 1996, Infection and immunity.

Safety and immunogenicity of live oral cholera and typhoid vaccines administered alone or in combination with antimalarial drugs, oral polio vaccine, or yellow fever vaccine.

S. Cryz, C. Herzog, C. Kunz, 1997, The Journal of infectious diseases.

Compatible concurrent administration of yellow fever 17D vaccine with oral, live, attenuated p6olera CVD103-HgR and typhoid ty21a vaccines.

C. B. Cropp, S. Cryz, C. Herzog, 1999, The Journal of infectious diseases.

Safety and immunogenicity of a polyvalent Escherichia coli vaccine in human volunteers.

A. Cross, A. Artenstein, S. Cryz, 1994, The Journal of infectious diseases.

Immunity against Pseudomonas aeruginosa adoptively transferred to bone marrow transplant recipients.

H. Prentice, S. Cryz, M. Brenner, 1990, Blood.

Plasmodium falciparum circumsporozoite vaccine immunogenicity and efficacy trial with natural challenge quantitation in an area of endemic human malaria of Kenya.

G. Strickland, J. Wittes, C. Roberts, 1996, Vaccine.

Purification of Pseudomonas aeruginosa exoenzyme S

D. Woods, J. Que, 1987, Infection and immunity.

Vaccination of Cystic Fibrosis Patients Against Pseudomonas aeruginosa Reduces the Proportion of Patients Infected and Delays Time to Infection

U. Schaad, A. Lang, M. Schöni, 2004, The Pediatric infectious disease journal.